TAKEDA PHARMACEUTICAL CO LTD - 26 May 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
10%+ Owner
Signature
/s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol
PHAT
Transactions as of
26 May 2021
Net transactions value
-$766,700
Form type
4
Filing time
28 May 2021, 06:11:14 UTC
Previous filing
26 May 2021
Next filing
02 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale $272,245 -7,469 -0.75% $36.45 982,127 26 May 2021 Direct F1, F2
transaction PHAT Common Stock Sale $180,502 -4,889 -0.5% $36.92 977,238 26 May 2021 Direct F1, F3
transaction PHAT Common Stock Sale $228,376 -6,174 -0.63% $36.99 971,064 27 May 2021 Direct F1, F4
transaction PHAT Common Stock Sale $85,576 -2,279 -0.23% $37.55 968,785 27 May 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
F2 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.71 to $36.70. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F3 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.72 to $37.22. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F4 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.35 to $37.33. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F5 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $37.34 to $37.92. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.